The RightMed® comprehensive test is a provider-ordered pharmacogenomic test that analyzes a patient’s DNA to determine how he or she may respond to hundreds of medications used to treat and manage many medical conditions. This information, provided in both static and interactive reports, may help providers make more informed prescription decisions, protect patients from adverse drug reactions and drug ineffectiveness, and reduce healthcare costs.
The RightMed comprehensive test covers hundreds of commonly prescribed medications, including omeprazole (Prilosec), simvastatin (Zocor), citalopram (Celexa), clopidogrel (Plavix), warfarin (Coumadin), codeine, alprazolam (Xanax), phenytoin (Dilantin), metoprolol (Lopressor), plus many more.
The RightMed comprehensive test covers medications used for many medical conditions.
The RightMed comprehensive test analyzes genes involved in drug metabolism, drug targets, drug receptors, and drug transporters. Analysis is provided for genes that have been shown, based on OneOme's rigorous research and standards for inclusion, to affect how a patient responds to many commonly prescribed medications.
|CYP1A2||*1C, *1D, *1E, *1F, *1J, *1K, *1L, *1V, *1W|
|CYP2B6||*4, *5, *6, *7, *9, *16, *18|
|CYP2C9||*2, *3, *4, *5, *6, *8, *11, *18|
|CYP2C19||*2, *3, *4, *4B, *10, *17|
|CYP2D6||*2A, *2, *3, *4, *4N, *4M, *5, *6, *6C, *7, *8, *9, *10, *11, *12, *13, *14A, *14B, *15, *17, *18, *19, *29, *31, *34, *35, *36, *39, *41, *42, *63, *64, *68, *69, *70, *91, *109|
|CYP3A5||*3, *6, *7|
|DPYD||*2A (1905+1G>A, IVS14+1G>A), Asp949Val, *13|
|DRD2||Promoter variant -241A>G|
|F5||Arg534Gln (Leiden, 1691G>A)|
|GRIK4||Non-coding (intronic) T>C variant|
|HTR2A||Intron 2, T>C variant|
|HTR2C||Promoter variant -759C>T|
|IL28B (IFNL4)||Non-coding (intronic) C>T variant|
|SLCO1B1||*5, *17, *21|
|TPMT||*2, *3A, *3B, *3C, *4|
|UGT1A1||*6, *28 (TA7)|
|VKORC1||Promoter variant -1639G>A|
RightMed comprehensive test report
With the RightMed comprehensive test, providers receive a clinically actionable report that categorizes drugs into a simple, easy-to-read format:
Providers may use the information from the test report to guide medication and dosage decisions based on the patient's DNA, the drug binning, and clinical annotations.
The RightMed Advisor
Providers also have access to the RIGHTMED ADVISOR, an interactive tool to help providers quickly and easily interpret test results, explore more information about the hundreds of drugs in OneOme’s database, evaluate drug-to-drug interactions, and view curated medication alternatives.
Providers can generate custom reports by selecting the medications they would like displayed in a RightMed Advisor custom report, which helps providers get more in-depth information and focus on the drugs that matter the most for each patient.
In addition to the RightMed comprehensive test report, providers can generate additional reports, including RightMed Advisor reports and specialty reports.
The RightMed Advisor reports are built by the provider selecting which medications they would like highlighted, giving them the power to build their own in-depth, customized report.
Specialty reports include a subset of medications selected and classified by OneOme’s clinical team.